Nithya Desikan - Net Worth and Insider Trading

Nithya Desikan Net Worth

The estimated net worth of Nithya Desikan is at least $3 Million dollars as of 2024-11-10. Nithya Desikan is the Chief Commercial Officer of Rhythm Pharmaceuticals Inc and owns about 43,602 shares of Rhythm Pharmaceuticals Inc (RYTM) stock worth over $3 Million. Details can be seen in Nithya Desikan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nithya Desikan has not made any transactions after 2020-08-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Nithya Desikan

To

Nithya Desikan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nithya Desikan owns 1 companies in total, including Rhythm Pharmaceuticals Inc (RYTM) .

Click here to see the complete history of Nithya Desikan’s form 4 insider trades.

Insider Ownership Summary of Nithya Desikan

Ticker Comapny Transaction Date Type of Owner
RYTM Rhythm Pharmaceuticals Inc 2020-08-31 Chief Commercial Officer

Nithya Desikan Latest Holdings Summary

Nithya Desikan currently owns a total of 1 stock. Nithya Desikan owns 43,602 shares of Rhythm Pharmaceuticals Inc (RYTM) as of August 31, 2020, with a value of $3 Million.

Latest Holdings of Nithya Desikan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RYTM Rhythm Pharmaceuticals Inc 2020-08-31 43,602 67.33 2,935,723

Holding Weightings of Nithya Desikan


Nithya Desikan Form 4 Trading Tracker

According to the SEC Form 4 filings, Nithya Desikan has made a total of 2 transactions in Rhythm Pharmaceuticals Inc (RYTM) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Rhythm Pharmaceuticals Inc is the sale of 25,000 shares on August 31, 2020, which brought Nithya Desikan around $750,000.

Insider Trading History of Nithya Desikan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nithya Desikan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Nithya Desikan Ownership Network

Ownership Network List of Nithya Desikan

No Data

Ownership Network Relation of Nithya Desikan

Insider Network Chart

Nithya Desikan Owned Company Details

What does Rhythm Pharmaceuticals Inc do?

Who are the key executives at Rhythm Pharmaceuticals Inc?

Nithya Desikan is the Chief Commercial Officer of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include Chief Human Resources Officer Pamela J. Cramer , Chief Technical Officer Joseph Shulman , and Corporate Controller & CAO Christopher Paul German .

Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary

Over the past 18 months, Nithya Desikan made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 171,662 shares made by Joseph Shulman , a net sale of 85,162 shares made by Pamela J. Cramer , and a net sale of 78,894 shares made by Jennifer Chien .

In summary, during the past 3 months, insiders sold 135,174 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 135,174 shares. During the past 18 months, 592,041 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 592,041 shares.

Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Rhythm Pharmaceuticals Inc Insider Transactions

No Available Data

Nithya Desikan Mailing Address

Above is the net worth, insider trading, and ownership report for Nithya Desikan. You might contact Nithya Desikan via mailing address: 82 Bay State Road, Belmont Ma 02478.